IGF1 and Stroke: Thus, our primary objective was to investigate whether intra-individual changes in post-stroke s-IGF-I (ΔIGF-I), from the acute phase to 3 months post-IS, are associated with functional independence 3 months after the IS, and if so, whether ΔIGF-I is also associated with functional outcome 2 years after IS.